These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7033184)
1. Radiation dose to bladder wall following the administration of 99mTc-microspheres and 99mTc-DTPA. Smith T Health Phys; 1981 Nov; 41(5):777-80. PubMed ID: 7033184 [No Abstract] [Full Text] [Related]
2. Radiation doses from technetium-99m DTPA administered as an aerosol. Barber RW J Nucl Med; 1985 Oct; 26(10):1190-4. PubMed ID: 3900308 [TBL] [Abstract][Full Text] [Related]
3. Radiation absorbed dose from technetium-99m DTPA. Smith T; Zanelli GD; Veall N J Nucl Med; 1987 Feb; 28(2):240-3. PubMed ID: 3100735 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of simultaneously administered 99mTc-DTPA and (125I)ortho-iodohippuran in rats and rabbits]. Láznícková A; Láznícek M; Kvĕtina J; Kraus K; Kusák V Cesk Farm; 1985 Mar; 34(2):67-70. PubMed ID: 3891107 [No Abstract] [Full Text] [Related]
5. Re: Radiation absorbed dose from Tc-99m diethylenetriaminepentaacetic acid (DTPA). Smith T J Nucl Med; 1984 Dec; 25(12):1392. PubMed ID: 6389795 [No Abstract] [Full Text] [Related]
8. [Ventilation scintigraphy of the lung with 99mTc-DTPA or with 99mTc-sulfur colloid?]. Köhler D; Coates G; Dolovich M; Newhouse M; Matthys H Nuklearmedizin; 1983 Apr; 22(2):115-9. PubMed ID: 6346270 [TBL] [Abstract][Full Text] [Related]
9. MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations. Task Group of the MIRD Committee, Society of Nuclear Medicine. Thomas SR; Stabin MG; Chen CT; Samaratunga RC J Nucl Med; 1999 Apr; 40(4):102S-123S. PubMed ID: 10210232 [TBL] [Abstract][Full Text] [Related]
10. In vitro study of the in vivo behaviour of 99mTc-DTPA. Jeghers O; Piepsz A; Ermans AM J Nucl Med Allied Sci; 1981; 25(1-2):1-3. PubMed ID: 7019395 [No Abstract] [Full Text] [Related]
11. Computer package for the calculation of the radiation dose to patients, based on the MIRD approach. Pan ZY; Wolf W J Nucl Med; 1985 Mar; 26(3):318-20. PubMed ID: 3882906 [No Abstract] [Full Text] [Related]
12. [Renography with a gammacamera. Comparison between 131I-Hippuran and 99mTc-DTPA]. Rehling M; Møller ML; Lund JO; Trap-Jensen J Ugeskr Laeger; 1982 Sep; 144(37):2713-6. PubMed ID: 6758265 [No Abstract] [Full Text] [Related]
13. [Exercise renography with two-time injection of 99mTc-DTPA at a short interval--deconvolution analysis in normal subjects and patients with essential hypertension]. Kubota Y; Miyao K; Mineo T; Okajima Y; Kusuoka S; Murata M; Kotera H; Yamada C; Sugihara H; Adachi H Kaku Igaku; 1986 Mar; 23(3):267-71. PubMed ID: 3525916 [No Abstract] [Full Text] [Related]
14. [Phase I clinical study of 99mTc-DTPA-human serum albumin]. Tamaki N; Yonekura Y; Nishizawa S; Fujita T; Konishi J; Torizuka K Kaku Igaku; 1988 Jun; 25(6):579-88. PubMed ID: 3225966 [No Abstract] [Full Text] [Related]
15. Assessment of radiation dose to infants from breast milk following the administration of 99mTc pertechnetate to nursing mothers. Ogunleye OT Health Phys; 1983 Jul; 45(1):149-51. PubMed ID: 6307926 [No Abstract] [Full Text] [Related]
16. A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid. II: Human dynamic and imaging studies. Galli G; Maini CL; Orlando P; Cobelli C; Thomaset K; Deleide G; Valle G J Nucl Med Allied Sci; 1988; 32(2):117-26. PubMed ID: 3049962 [No Abstract] [Full Text] [Related]